Physician profile
Anna Sessi
NPI 1689602310
$2,963.95
in general payments reported to CMS, 2019-2025
38 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $107 · 2022: $11.67 · 2023: $531 · 2024: $694 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608 · Education: $6.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,608.24 |
| Education | $6.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.40 | 2023-2025 | Vraylar, Linzess, Viberzi |
| Novo Nordisk INC | $302.03 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $279.60 | 2023-2025 | Kisunla, Mounjaro, Jardiance |
| Sumitomo Pharma America, INC. | $266.59 | 2023-2025 | Gemtesa, Myfembree |
| Astrazeneca Pharmaceuticals Lp | $232.88 | 2020-2025 | Farxiga, Airsupra |
| Amgen INC. | $190.68 | 2019-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $126.12 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $119.24 | 2023-2025 | |
| Astellas Pharma US INC | $116.69 | 2023-2025 | Veozah |
| Pfizer INC. | $94.09 | 2023-2025 | |
| Exact Sciences Corporation | $86.11 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sonex Health, INC. | $71.98 | 2024 | Sx-One Microknife |
| Dexcom, INC. | $63.32 | 2023-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $62.10 | 2019-2024 | Capvaxive, Gardasil 9, Gardasil |
| Cleerly, INC. | $55.22 | 2025 | Cleerly Labs, Cleerly Ischemia |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sessi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.